Estrogen inducibility of c-Ha-ras transcription in breast cancer cells -: Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene

被引:37
作者
Pethe, V
Shekhar, PVM
机构
[1] Karmanos Canc Inst, Breast Canc Program, Detroit, MI 48201 USA
[2] Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA
[3] Wayne State Univ, Detroit, MI 48201 USA
关键词
D O I
10.1074/jbc.274.43.30969
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although mutation of ras gene is rare in human breast cancer, overexpression of normal c-Ha-ras gene is frequently observed. Using a mouse mammary metastasis model consisting of genetically related mammary tumor sublines with variant metastatic potential, we have previously (i) demonstrated a direct correlation between c-Ha-ras mRNA and protein levels and metastatic potential and (ii) identified a novel hormone-responsive transcriptional regulatory element in intron 1 of the mouse c-Ha-ras gene that contains the consensus half-site of a glucocorticoid response element and flanking consensus half-sites for estrogen response element. Here, we have examined the functionality of intron 1 sequence in context of upstream sequences by using transient transfection assays with plasmids expressing chloramphenicol acetyltransferase. Intron 1 sequence and sequences similar to intron 1 element located in exon 1 function as transcriptional regulatory elements that confer hormonal inducibility to chloramphenicol acetyltransferase gene expression both independently and in context of 5'-flanking sequences, Measurement of c-Ha-ras transcription rates and protein expression by nuclear run-on and metabolic labeling assays showed a 5-12-fold enhancement, respectively, following treatment with 17 beta-estradiol that was blunted by ICI 182,780 in the nonmetastatic variant, In contrast, constitutive overexpression of c-Ha-ras transcripts and protein in the metastatic subline was unaffected by estrogen and ICI 182,780. Gel shift assays demonstrated specific interaction of c-Ha-ras exon 1 sequence with nuclear proteins of human breast cancer MCF-7 cells with formation of two complexes, one of which contains estrogen receptor, Our data demonstrate a direct (i) interaction of c-Ha-ras sequence with estrogen receptor and (ii) stimulatory effect of estrogen on c-Ha-ras gene transcription and suggest that alteration in transcriptional regulation of c-Ha-ras gene by estrogen may play an important role in progression of breast cancer.
引用
收藏
页码:30969 / 30978
页数:10
相关论文
共 56 条
[31]   ELEVATED EXPRESSION OF HA-RAS IS AN EARLY EVENT IN 2-STAGE SKIN CARCINOGENESIS IN SENCAR MICE [J].
PELLING, JC ;
ERNST, SM ;
STRAWHECKER, JM ;
JOHNSON, JA ;
NAIRN, RS ;
SLAGA, TJ .
CARCINOGENESIS, 1986, 7 (09) :1599-1602
[32]   TRANSFORMATION OF MOUSE FIBROBLASTS WITH THE ONCOGENES H-RAS OR TRK IS ASSOCIATED WITH PRONOUNCED CHANGES IN DRUG SENSITIVITY AND METABOLISM [J].
PETERS, GJ ;
WETS, M ;
KEEPERS, YPAM ;
OSKAM, R ;
VANARKOTTE, J ;
NOORDHUIS, P ;
SMID, K ;
PINEDO, HM .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (03) :450-455
[33]   NUCLEOTIDE-SEQUENCE ANALYSIS OF THE T24 HUMAN BLADDER-CARCINOMA ONCOGENE [J].
REDDY, EP .
SCIENCE, 1983, 220 (4601) :1061-1063
[34]   A POINT MUTATION IS RESPONSIBLE FOR THE ACQUISITION OF TRANSFORMING PROPERTIES BY THE T24 HUMAN BLADDER-CARCINOMA ONCOGENE [J].
REDDY, EP ;
REYNOLDS, RK ;
SANTOS, E ;
BARBACID, M .
NATURE, 1982, 300 (5888) :149-152
[35]   NUCLEOTIDE-SEQUENCE OF THE 2 RAT CELLULAR RASH GENES [J].
RUTA, M ;
WOLFORD, R ;
DHAR, R ;
DEFEOJONES, D ;
ELLIS, RW ;
SCOLNICK, EM .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (05) :1706-1710
[36]   CISPLATIN RESISTANCE IN HUMAN CANCERS [J].
SCANLON, KJ ;
KASHANISABET, M ;
TONE, T ;
FUNATO, T .
PHARMACOLOGY & THERAPEUTICS, 1991, 52 (03) :385-406
[37]   ENHANCEMENT OF NATURAL-KILLER-CELL SUSCEPTIBILITY OF HUMAN BREAST-CANCER CELLS BY ESTRADIOL AND V-HA-RAS ONCOGENE [J].
SCREPANTI, I ;
FELLI, MP ;
TONIATO, E ;
MECO, D ;
MARTINOTTI, S ;
FRATI, L ;
SANTONI, A ;
GULINO, A .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (03) :445-449
[38]  
SHEKHAR PVM, 1994, INVAS METAST, V14, P27
[39]  
SHEKHAR PVM, 1995, CANC MOL BIOL, V2, P529
[40]  
SKLAR MD, 1988, CANCER RES, V48, P793